The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma.

By M. Gordon, J. Beiser, J. Brandt, D. Heuer, E. Higginbotham, Chris A. Johnson, J. Keltner, J. Miller, R. Parrish, M. Wilson and 1 more. A M A Archives of Ophthalmology, 2002

2,771 citations recorded by the source corpus.

Subfields: Ophthalmology, Public Health, Environmental and Occupational Health, Radiology, Nuclear Medicine and Imaging

View Paper: https://www.semanticscholar.org/paper/80ccdc201c173ba599298fdfcb910915a3ea5e42

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. Seang Mei Saw
2. W. Chua
3. Edwin Chan Shih-Yen
4. G. Gazzard

Citations in the corpus

• Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. (2003, neutral): “39 95 221 (54) Hypertension§ Yes 98 (51) 0.”
• Myopia and associated pathological complications (2005, background): “In the Ocular Hypertension Treatment Study (OHTS) of the effect of topical ocular hypotensive medication in preventing the onset of POAG, myopia (a baseline risk factor) was not associated with incident POAG (Gordon et al., 2002).”